BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6928244)

  • 1. A new mouse tumor model system (RIF-1) for comparison of end-point studies.
    Twentyman PR; Brown JM; Gray JW; Franko AJ; Scoles MA; Kallman RF
    J Natl Cancer Inst; 1980 Mar; 64(3):595-604. PubMed ID: 6928244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin.
    Kripke ML; Gruys E; Fidler IJ
    Cancer Res; 1978 Sep; 38(9):2962-7. PubMed ID: 679204
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages.
    Brown JM; Twentyman PR; Zamvil SS
    J Natl Cancer Inst; 1980 Mar; 64(3):605-11. PubMed ID: 6928245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic control of metastatic competence of cloned tumor cell populations.
    Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M
    Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection and biologic properties of malignant variants of a murine lymphosarcoma.
    Brunson KW; Nicolson GL
    J Natl Cancer Inst; 1978 Dec; 61(6):1499-503. PubMed ID: 281557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
    Wu GJ; Fu P; Wang SW; Wu MW
    Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells.
    Chambers AF; Hill RP; Ling V
    Cancer Res; 1981 Apr; 41(4):1368-72. PubMed ID: 7214323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury.
    Hanson WR; Zhen W; Geng L; Hunter N; Milas L
    Radiat Res; 1995 Jun; 142(3):281-7. PubMed ID: 7761578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased radiosensitivity of a recurrent murine fibrosarcoma following radiotherapy.
    Ando K; Koike S; Ikehira H; Hayata I; Shikita M; Yasukawa M
    Jpn J Cancer Res; 1985 Feb; 76(2):99-103. PubMed ID: 3920106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.
    Wysocki PJ; Kwiatkowska EP; Kazimierczak U; Suchorska W; Kowalczyk DW; Mackiewicz A
    Clin Cancer Res; 2006 Jul; 12(13):4095-102. PubMed ID: 16818710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
    Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
    Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle dependency of metastatic lung colony formation.
    Suzuki N; Frapart M; Grdina DJ; Meistrich ML; Withers HR
    Cancer Res; 1977 Oct; 37(10):3690-3. PubMed ID: 908016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and serum dependence of cloned cell lines undergoing spontaneous malignant transformation in culture.
    Sanford KK; Handleman SL; Jones GM
    Cancer Res; 1977 Mar; 37(3):821-30. PubMed ID: 837379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrifugal elutriation and characterization of tumor cells from venous blood of tumor-bearing mice: possible relevance to metastasis.
    Suzuki N
    Cancer Res; 1984 Aug; 44(8):3505-11. PubMed ID: 6744276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.